WASHINGTON (Reuters)- U.S. Food and Drug Administration chief, Scott Gottlieb, criticized pharmacy benefit managers, health insurers and drugmakers on Wednesday for «Kabuki drug - pricing constructs» that profit the industry at the expense of consumers. (reuters.com)
Clearly, harmonization aims to help businesses at the expense of consumers. (progressive-economics.ca)
One of my bitch points is the lack of transparency that comes from the obfuscation and stealing of the English language by the broker - dealer world to their benefit and at the expense of the consumer. (thinkadvisor.com)